Betamethasone Dipropionate Ointment
Product Images NDC 0472-0381

2 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Betamethasone Dipropionate (NDC 0472-0381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

14c51497-figure-01 (Image 1)

14c51497-figure-01 (Image 1)
Chemical structure diagram of Betamethasone Dipropionate, showing its molecular arrangement. The diagram includes ring structures, various carbon, hydrogen, and oxygen atoms, and functional groups consistent with the corticosteroid compound Betamethasone Dipropionate.*
FDA Label Image

Image (Image 2)

Image (Image 2)
Packaging label for Betamethasone Dipropionate Ointment USP 0.05%, topical ointment, 15g (0.53 oz) tubes, labeled for dermatologic use only, not for ophthalmic use. The label shows the product name, strength, Rx only designation, NDC 0472-0381-15, and is from Actavis Pharma, Inc. The carton includes usage instructions, storage conditions, and tamper-evident seal information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.